Literature DB >> 10203710

Where have all the T cells gone? Mechanisms of immune evasion by tumors.

J Finke1, S Ferrone, A Frey, A Mufson, A Ochoa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10203710     DOI： 10.1016/s0167-5699(98)01435-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  30 in total

1.  Innate immunity to carcinomas?

Authors:  S J Golby; J Spencer
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

2.  CD70 expression patterns in renal cell carcinoma.

Authors:  Lucia B Jilaveanu; Joshua Sznol; Saadia A Aziz; Dylan Duchen; Harriet M Kluger; Robert L Camp
Journal:  Hum Pathol       Date:  2012-03-07       Impact factor: 3.466

Review 3.  VEGF as a mediator of tumor-associated immunodeficiency.

Authors:  J E Ohm; D P Carbone
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

4.  Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.

Authors:  Yu-Qing Shen; Jian-Qiong Zhang; Feng-Qing Miao; Jian-Min Zhang; Qin Jiang; Hao Chen; Xiang-Nian Shan; Wei Xie
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

5.  Characterization of gene expression profiles of T cells during anti-tumor response.

Authors:  Christian Stremmel; Renate Siebenhaar; Roland Croner; Bertram Reingruber; Anthony J Slavin; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2005-04-06       Impact factor: 2.571

6.  The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.

Authors:  Suhnrita Chaudhuri; Manoj Kumar Singh; Debanjan Bhattacharya; Sagar Acharya; Sirshendu Chatterjee; Pankaj Kumar; Pushpak Bhattacharjee; Anjan Kumar Basu; Gaurisankar Sa; Tanya Das; Tushar Kanti Ghosh; Swapna Chaudhuri
Journal:  J Neurooncol       Date:  2014-07-16       Impact factor: 4.130

Review 7.  Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Authors:  Julia Kravchenko; Emanuela Corsini; Marc A Williams; William Decker; Masoud H Manjili; Takemi Otsuki; Neetu Singh; Faha Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Anna Maria Colacci; Monica Vaccari; Chiara Mondello; A Ivana Scovassi; Jayadev Raju; Roslida A Hamid; Lorenzo Memeo; Stefano Forte; Rabindra Roy; Jordan Woodrick; Hosni K Salem; Elizabeth P Ryan; Dustin G Brown; William H Bisson; Leroy Lowe; H Kim Lyerly
Journal:  Carcinogenesis       Date:  2015-05-22       Impact factor: 4.944

8.  Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.

Authors:  Omar A Al Obeed; Khayal A Alkhayal; Abdulmalik Al Sheikh; Ahmad M Zubaidi; Mansoor-Ali Vaali-Mohammed; Robin Boushey; James H Mckerrow; Maha-Hamadien Abdulla
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

9.  Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.

Authors:  Christopher E Touloukian; Wolfgang W Leitner; Rhonda E Schnur; Paul F Robbins; Yong Li; Scott Southwood; Alessandro Sette; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

10.  Tumor-shed PGE(2) impairs IL2Rgammac-signaling to inhibit CD4 T cell survival: regulation by theaflavins.

Authors:  Sreya Chattopadhyay; Sankar Bhattacharyya; Baisakhi Saha; Juni Chakraborty; Suchismita Mohanty; Dewan Md Sakib Hossain; Shuvomoy Banerjee; Kaushik Das; Gaurisankar Sa; Tanya Das
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.